Tirzepatide: FDA approved and widely available Tirzepatide received FDA approval for type 2 diabetes (as Mounjaro) in 2022 and for chronic weight management (as Zepbound) in 2023
J Clin Epidemiol 62(10):e1-34 Maes M, Mihaylova I, Kubera M et al (2011) Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression
Nature , 432 (7016), 466472
In preclinical studies, BPC-157 has been observed to influence certain biological pathways associated with tissue integrity
instead we aim for healthy, even skin
Too much or too little of key electrolytes (like sodium or potassium) can cause issues like muscle cramps, irregular heartbeat, or neurological symptoms